题名

淺談新冠肺炎（COVID-19）之藥物治療

DOI

10.6647/CN.202109_28(3).0002

作者

賴穎萱；徐雅玫

关键词
期刊名称

彰化護理

卷期/出版年月

28卷3期（2021 / 09 / 01）

页次

2 - 7

内容语文

繁體中文
主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, opelabel, platform trial. Lancet (London, England), 397(10285), 1637–1645.
    連結：
  2. REMAP-CAP Investigators, Gordon, A. C., Mouncey, P. R., Al-Beidh, F., Rowan, K. M., Nichol, A. D., Arabi, Y. M., Annane, D., Beane, A., van Bentum-Puijk, W., Berry, L. R., Bhimani, Z., Bonten, M., Bradbury, C. A., Brunkhorst, F. M., Buzgau, A., Cheng, A. C., Detry, M. A., Duffy, E. J., Estcourt, L. J., … Derde, L. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. The New England journal of medicine, 384(16), 1491–1502.
    連結：
  3. Ghosn, L., Chaimani, A., Evrenoglou, T., Davidson, M., Graña, C., Schmucker, C., Bollig, C., Henschke, N., Sguassero, Y., Nejstgaard, C. H., Menon, S., Nguyen, T. V., Ferrand, G., Kapp, P., Riveros, C., Ávila, C., Devane, D., Meerpohl, J. J., Rada, G., Hróbjartsson, A., … Boutron, I. (2021). Interleukin-6 blocking agents for treating COVID-19: a living systematic review. The Cochrane database of systematic reviews, 3, CD013881.
    連結：
  4. Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G., … ACTT-1 Study Group Members (2020). Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine, 383(19), 1813–1826.
    連結：
  5. WHO Solidarity Trial Consortium, Pan, H., Peto, R., Henao-Restrepo, A. M., Preziosi, M. P., Sathiyamoorthy, V., Abdool Karim, Q., Alejandria, M. M., Hernández García, C., Kieny, M. P., Malekzadeh, R., Murthy, S., Reddy, K. S., Roses 6 2021年09月∣第28卷第3期　www2.cch.org.tw/layout_5/index.aspx?id=5100 醫護論述 Periago, M., Abi Hanna, P., Ader, F., Al-Bader, A. M., Alhasawi, A., Allum, E., Alotaibi, A., … Swaminathan, S. (2021). Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. The New England journal of medicine, 384(6), 497– 511.
    連結：
  6. 行政院衛生福利部疾病管制署(2021)‧新型冠狀病 毒(SARS-CoV-2)感染臨床處置暫行指引第十三 版。取自 https://www.cdc.gov.tw/Category/Page/ xCSwc5oznwcqunujPc-qmQ
  7. WHO(2021). WHO Coronavirus (COVID-19) Dashboard. Retrieved July 23, 2021, from https://covid19.who. int/
  8. National Institutes of Health (NIH). Coronavirus disease (COVID-19) treatment guidelines. Updated July 8, 2021. Retrieved July 20, 2021, from https://www. covid19treatmentguidelines.nih.gov.
  9. Kim, A. Y., & Gandhi, R.T. (2021) COVID-19: Management in hospitalized adults. UpToDate. Retrieved July 21, 2021, from https://www.uptodate. com/contents/covid-19-management-in-hospitalizeadult
  10. Dexamethasone (systemic): Drug information. UpToDate. Retrieved July 2021a, from https://www.uptodate. com/contents/dexamethasone-systemic-druinformation
  11. Baricitinib: Drug information. UpToDate. Retrieved July 2021b, from https://www.uptodate.com/contents/ baricitinib-drug-information
  12. Tocilizumab: Drug information. UpToDate. Retrieved July 2021c, from https://www.uptodate.com/ contents/tocilizumab-drug-information
  13. Remdesivir: Drug information. UpToDate. Retrieved July 2021d, from https://www.uptodate.com/contents/ remdesivir-drug-information
print cancel